NVST Company Profile and Key Details

Q: Who are the executives of NVST?

Ms. Claudia OrtizSenior Vice President of Regulatory Affairs & Quality AssuranceMr. Amir AghdaeiPres, Chief Executive Officer & DirectorMr. Jean-Claude E. KyrillosSenior Vice President and Pres of Diagnostics & Digital SolutionsStephen KellerVice President of Investor RelationsMr. Eric ConleySenior Vice President & Pres of OrthodonticsMr. Filippo ImpieriSenior Vice President of Special MarketsJuan ArbonaChief Compliance OfficerMr. Mark E. NanceSenior Vice President, Gen. Counsel & Sec.Mr. Mischa M. ReisSenior Vice President of Strategy & Corporation Devel.Mr. Patrik ErikssonSenior Vice President & Pres of Nobel BiocareMr. Howard H. YuSenior Vice President & Chief Financial OfficerMr. Stephen KellerVice President of Investor Relations

NYSE : NVST

Envista

$22.46

0.175+0.79%

Open: 2:57 PM

73.96

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Envista Holdings Corp (NVST) stock surged +0.79%, trading at $22.46 on NYSE, up from the previous close of $22.28. The stock opened at $22.28, fluctuating between $22.28 and $22.67 in the recent session.

Stock Snapshot

22.28

Prev. Close

3.69B

Market Cap

22.28

Day Low

249.5

P/E Ratio

0.09

EPS (TTM)

1.27

Cash Flow per Share

22.28

Open

164.43M

Number of Shares

22.67

Day High

99.61%

Free Float in %

24.31

Book Value

1.37M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 19, 2025	22.19	22.40	21.99	22.28	4.23M
Dec 17, 2025	21.88	22.03	21.59	21.85	2.55M
Dec 16, 2025	22.01	22.23	21.53	21.90	3.05M
Dec 15, 2025	22.15	22.40	21.91	22.06	2.27M
Dec 12, 2025	22.18	22.30	21.76	21.97	2.05M
Dec 11, 2025	22.17	22.43	21.99	22.14	2.14M
Dec 10, 2025	20.73	22.48	20.73	22.10	4.48M
Dec 09, 2025	20.24	21.07	19.89	20.62	2.62M
Dec 08, 2025	20.23	20.42	19.99	20.01	1.95M
Dec 05, 2025	20.16	20.46	20.03	20.23	2.41M
Dec 04, 2025	20.36	20.53	20.05	20.13	1.76M
Dec 03, 2025	20.32	20.57	20.25	20.45	1.74M
Dec 02, 2025	20.82	20.82	20.17	20.18	2.37M
Dec 01, 2025	20.60	20.89	20.60	20.77	830.72K
Nov 28, 2025	20.95	21.10	20.83	20.90	570.06K
Nov 26, 2025	21.03	21.13	20.81	20.99	1.42M
Nov 25, 2025	20.30	21.07	20.22	21.05	2.14M
Nov 24, 2025	19.92	20.47	19.67	20.20	2.07M
Nov 21, 2025	19.17	20.15	19.17	19.89	1.61M
Nov 20, 2025	19.08	19.32	18.90	19.11	1.61M

Contact Details

Brea, CA 92821-6208

United States

http://www.envistaco.com 171 451 67774

About Company

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Stock Peers

Labcorp Holdings Inc.$252.03 HIMS

0.79+2.27%

Hims & Hers Health, Inc.$35.56 CON

-0.19-0.97%

Concentra Group Holdings Parent, Inc.$19.43 NEUE

NeueHealth, Inc.$6.75

Company Overview

Envista Holdings Corp (NYSE:NVST) closed at $22.45 USD, gaining $0.17 (0.79%) from the previous close of $22.28. The stock is currently trading near its 52-week high $14.22 and $22.68. With a market capitalization of about $3.69 billion, Envista Holdings Corp is classified as a mid-cap and shows market-like volatility (beta ~1.03). Key stats such as the average daily volume over the past year has been around 2.15 million shares, volume is running light vs its 52-week average. Headquartered in Brea, CA, Envista Holdings Corp operates in the Healthcare sector and the Medical - Equipment & Services industry. Led by CEO Paul A. Keel, the company employs approximately 12,300 people and listed since September 18, 2019. Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions.

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 5.6%, SMA50 9.67%, SMA200 15.9%). The stock’s 14-day RSI is 67.14 (firm momentum), while the ATR of 0.61 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -1.76% below its high and over 56.68% above its low. Average 10-day trading volume of 2.83 million shares is slightly above the 3-month average of 2.05 million, indicating heightened recent market interest.

Valuation Metrics

Envista Holdings Corp trades at a P/E ratio of 246.39, slightly above the S&P 500 average, with a price-to-sales ratio of 1.4 and a price-to-book ratio of 1.22 suggesting the stock is closer to book value. The P/FCF stands at 13.96, also above market averages.

Dividend & Fair Value

Envista Holdings Corp last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $49.14. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of 24.48% annually over the next five years. The latest quarter delivered EPS of -$0.18. The next quarter is forecast at $0.32. Next year's EPS is expected at $4.38. Analyst sentiment is neutral. Analyst rating data shows there are 2 Strong Buy ratings, 1 Buy ratings, 13 Hold ratings, 0 Sell rating and 1 Strong Sell ratings. Price targets range from $25.00 to $17.00. The high target offers 12.21% upside. The low target suggests -23.7% downside. The mean target is $20.41. This offers -8.39% upside. Envista Holdings Corp earnings surprise history is a mixed track record. The quarter that ended October 29, 2025, missed forecasts by -152.33%. The prior quarter beat by 8.33%. Over the last six quarters, Apple has recorded several small beats. These include -59.26% in August 07, 2024.

Shareholding & Insider Activity

Envista Holdings Corp has 166.18 million shares outstanding. The public float is 165.49 million shares, elevated short interest at 6.93% of float. This equals 10.31 million shares. The short ratio is 3.96 days. Institutional investors hold 120.14% of the float. Insiders own 0.54%. Keel Paul A holds 402.60 thousand shares, Aghdaei Amir has 293.16 thousand shares and Conley Eric has 47.37 thousand shares. Over the past six months, insider transactions show net selling. They sold 15.00 thousand shares across 1 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Envista generated $2.57B in revenue, or $15.38 per share. Gross margin was 56.13%, operating margin 1.23%, and net profit margin -3.90%. Returns are negative, with ROA at -1.52% and ROE at -2.40%.
On valuation metrics, Envista trades at a P/E of 246.39, P/S of 1.40 and P/B of 1.22. The current ratio is 2.37 and quick ratio is 2.02. Operationally, the company’s inventory turnover is 4.03 and cash conversion cycle is 98.54 days. Debt-to-equity is 0.52, supported by a cash flow-to-debt ratio of 0.19.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Envista posted revenue of $2.57B, down slightly from $2.57B in the prior quarter. Gross profit was $1.44B (margin 56.13%). Operating income was $31.50M (margin 1.2%). Net income was- $100.20M (EPS - $0.60).
The company ended the quarter with $940.00M in cash and short-term investments, a total debt of $1.65B, and net debt of $713.60M. Total assets were $6.61B, with equity of $4.17B. Financials further reflected stability, with operating cash flow of $275.70M, free cash flow of $217.50M, and capital expenditures of - $58.20M.

Price Forecast & Outlook

Our AI price prediction model suggests that Envista Holdings Corp stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 5.03%, with price expected at $23.40 by January 02, 2026, within a range of $22.78 to $24.00 3-Month Outlook: Projected fall of -11.09%, reaching $19.81 by March 19, 2026, with a range of $19.53 to $20.04. 1-Year Outlook: Projected loss of -31.01%, with price at $15.37 by December 18, 2026, within a range of $13.90 to $16.98.

Key Takeaways

Envista Holdings Corp (NYSE:NVST) shares are up 15.5% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Envista Holdings Corp trading at a premium to the broader market with a P/E of 246.39. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $27.24, suggesting 22.26% upside. Our AI forecast model points to short-term strength (5.03% over two weeks), a medium-term fall (-11.09% over three months), and a longer-term loss (-31.01% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Envista Holdings Corp (NVST) stock price?

Envista Holdings Corp (NYSE: NVST) stock price is $22.46 in the last trading session. During the trading session, NVST stock reached the peak price of $22.67 while $22.28 was the lowest point it dropped to. The percentage change in NVST stock occurred in the recent session was 0.79% while the dollar amount for the price change in NVST stock was $0.18.

NVST's industry and sector of operation?

The NYSE listed NVST is part of Medical - Equipment & Services industry that operates in the broader Healthcare sector. Envista Holdings Corp designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NVST?

Ms. Claudia Ortiz
Senior Vice President of Regulatory Affairs & Quality Assurance
Mr. Amir Aghdaei
Pres, Chief Executive Officer & Director
Mr. Jean-Claude E. Kyrillos
Senior Vice President and Pres of Diagnostics & Digital Solutions
Stephen Keller
Vice President of Investor Relations
Mr. Eric Conley
Senior Vice President & Pres of Orthodontics
Mr. Filippo Impieri
Senior Vice President of Special Markets
Juan Arbona
Chief Compliance Officer
Mr. Mark E. Nance
Senior Vice President, Gen. Counsel & Sec.
Mr. Mischa M. Reis
Senior Vice President of Strategy & Corporation Devel.
Mr. Patrik Eriksson
Senior Vice President & Pres of Nobel Biocare
Mr. Howard H. Yu
Senior Vice President & Chief Financial Officer
Mr. Stephen Keller
Vice President of Investor Relations

How NVST did perform over past 52-week?

NVST's closing price is 56.68% higher than its 52-week low of $14.22 where as its distance from 52-week high of $22.68 is -1.76%.

How many employees does NVST have?

Number of NVST employees currently stands at 12,300.

Link for NVST official website?

Official Website of NVST is: http://www.envistaco.com

How do I contact NVST?

NVST could be contacted at phone 171 451 67774 and can also be accessed through its website. NVST operates from 200 S Kraemer Blvd Bldg E, Brea, CA 92821-6208, United States.

How many shares of NVST are traded daily?

NVST stock volume for the day was 1.37M shares. The average number of NVST shares traded daily for last 3 months was 2.15M.

What is the market cap of NVST currently?

The market value of NVST currently stands at $3.69B with its latest stock price at $22.46 and 164.43M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	12300
Beta	1.03
Sales or Revenue	$2.57B
5Y Sales Change%	-0.164%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Equipment & Services

NVST Company Profile and Key Details

Envista

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Valuation Metrics

Key Takeaways

Price Forecast & Outlook

Company Overview